Mostafa Mehdipour Ghazi,
Per Selnes,
Santiago Timon Reina,
Sandra Raquel Ramos Teceläo,
Silvia Ingala,
Atle Bjørnerud
et al.:
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts
Frontiers in Aging Neuroscience 2024
ARKIV /
DOI
Cecilia Magdalena Eriksson,
Bjørn-Eivind Seljelid Kirsebom,
Ragna Espenes,
Nikias Ioannis Siafarikas,
Knut Waterloo,
Arvid Rongve
et al.:
Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid Pathology
Dementia and Geriatric Cognitive Disorders Extra 2024
ARKIV /
DOI
Stephanie Knudtzon,
Kaja Nordengen,
Gøril Rolfseng Grøntvedt,
Jonas Alexander Jarholm,
Ingvild Vøllo Eliassen,
Per Selnes
et al.:
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s Disease
Fernando Gonzalez-Ortiz,
Bjørn-Eivind Seljelid Kirsebom,
José Contador,
Jordan E. Tanley,
Per Selnes,
Berglind Gisladottir
et al.:
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Anders Wimo,
Bjørn-Eivind Seljelid Kirsebom,
Santiago Timon Reina,
Ellen Vromen,
Per Selnes,
Jaka Bon
et al.:
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project
International Journal of Geriatric Psychiatry 2024
DOI
Sofia Egebäck Arulf,
Robin Ziyue Zhou,
Bjørn-Eivind Seljelid Kirsebom,
Alenka Jejcic,
Tormod Fladby,
Bengt Winblad
et al.:
Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases
Journal of Alzheimer's Disease 2024
DOI
Santiago Timón,
Mariano Rincón,
Rafael Martínez-Tomás,
Bjørn-Eivind Seljelid Kirsebom,
Tormod Fladby
:
A Knowledge Graph Framework for Dementia Research Data
Fredrik Öhman,
Marie Eckerström,
Erik Hessen,
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Ingrid Myrvoll Lorentzen
et al.:
Demographically adjusted Rey–Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49–77 years and comparison with North American norms
Scandinavian Journal of Psychology 2023
ARKIV /
DOI
Ingrid Myrvoll Lorentzen,
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Erik Hessen,
Knut K Waterloo,
Arne Exner Nakling
et al.:
Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer’s disease
Applied neuropsychology: Adult 2023
ARKIV /
DOI
Kaja Nordengen,
Bjørn-Eivind Seljelid Kirsebom,
Grit Richter,
Lene Pålhaugen,
Berglind Gisladottir,
Nikias Ioannis Siafarikas
et al.:
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Journal of Neuroinflammation 2023
ARKIV /
DOI
Mathilde Suhr Hemminghyth,
Luiza Chwiszczuk,
Monica Haraldseid Breitve,
Berglind Gisladottir,
Gøril Rolfseng Grøntvedt,
Arne Exner Nakling
et al.:
Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults
Jonas Alexander Jarholm,
Atle Bjørnerud,
Turi Olene Dalaker,
Mehdi Sadat Akhavi,
Bjørn-Eivind Kirsebom,
Lene Pålhaugen
et al.:
Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort
Journal of Alzheimer's Disease 2023
ARKIV /
DOI
Therese Händel Waggestad,
Bjørn-Eivind Kirsebom,
Carsten Strobel,
Anders Wallin,
Marie Eckerström,
Tormod Fladby
et al.:
Improving validity of the trail making test with alphabet support
Frontiers in Psychology 2023
ARKIV /
DOI
Klaus Thanke Aspli,
Jan Aaseth,
Trygve Holmøy,
Kaj Blennow,
Henrik Zetterberg,
Bjørn-Eivind Seljelid Kirsebom
et al.:
CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
Johan Jacob Espenes,
Ingrid Myrvoll Lorentzen,
Ingvild Vøllo Eliassen,
Erik Hessen,
Knut K Waterloo,
Santiago Timón
et al.:
Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20–85
The Clinical Neuropsychologist 2023
ARKIV /
DOI
Bjørn-Eivind Kirsebom,
Grit Richter,
Kaja Nordengen,
Dag Aarsland,
Geir Bråthen,
Betty M Tijms
et al.:
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Ingvild Vøllo Eliassen,
Bjørn-Eivind Kirsebom,
Tormod Fladby,
Knut Waterloo,
Sigrid Botne Sando,
Mathilde Suhr Hemminghyth
et al.:
Regression-Based Cognitive Change Norms Applied in Biochemically Defined Predementia Alzheimer’s Disease
Jacob Espenes,
Ingvild Vøllo Eliassen,
Fredrik Öhman,
Erik Hessen,
Knut K Waterloo,
Marie Eckerström
et al.:
Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49–79 and comparison with published norms
The Clinical Neuropsychologist 2022
ARKIV /
DOI
Miguel Germán Borda,
Daniel Ferreira,
Per Selnes,
Diego Alejandro Tovar-Rios,
Alberto Jaramillo-Jiménez,
Bjørn-Eivind Kirsebom
et al.:
Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness
Dementia and Geriatric Cognitive Disorders 2022
ARKIV /
DOI
Ingrid Myrvoll Lorentzen,
Johan Jacob Espenes,
Erik Hessen,
Knut Waterloo,
Geir Bråthen,
Santiago Timón
et al.:
Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample
Applied neuropsychology: Adult 2021
ARKIV /
DOI
Nikias Ioannis Siafarikas,
Bjørn-Eivind Kirsebom,
Deepak P Srivastava,
Cecilia Magdalena Eriksson,
Eirik Auning,
Erik Hessen
et al.:
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
Ingvild Vøllo Eliassen,
Tormod Fladby,
Bjørn-Eivind Kirsebom,
Knut Waterloo,
Marie Eckerström,
Anders Wallin
et al.:
Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia
Ragna Espenes,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Knut K Waterloo,
Erik Hessen,
Stein Harald Johnsen
et al.:
Amyloid plaques and symptoms of depression links to medical help-seeking due to subjective cognitive decline
Journal of Alzheimer's Disease 2020
ARKIV /
DOI
Johan Jacob Espenes,
Erik Hessen,
Ingvild Vøllo Eliassen,
Knut Waterloo,
Marie Eckerström,
Sigrid Botne Sando
et al.:
Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years
The Clinical Neuropsychologist 2020
ARKIV /
DOI
Anne Katrine Bergland,
Petroula Proitsi,
Bjørn-Eivind Kirsebom,
Hogne Sønnesyn,
Abdul Hye,
Alf Inge Larsen
et al.:
Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease
Journal of Alzheimer's Disease 2020
DOI
Kaja Nordengen,
Bjørn-Eivind Kirsebom,
Kristi Henjum,
Per Selnes,
Berglind Gisladottir,
Marianne Wettergreen
et al.:
Glial activation and inflammation along the Alzheimer's disease continuum
Journal of Neuroinflammation 2019
ARKIV /
DOI
Erik Hessen,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Carl Fredrik Andestad Eliassen,
Arne Nakling,
Geir Bråthen
et al.:
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
Journal of Alzheimer's Disease 2019
ARKIV /
DOI
Bjørn-Eivind Kirsebom,
Ragna Espenes,
Erik Hessen,
Knut Waterloo,
Stein Harald Johnsen,
Elisabeth Gundersen
et al.:
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
The Clinical Neuropsychologist 2019
ARKIV /
DOI
Bjørn-Eivind Kirsebom,
Kaja Nordengen,
Per Selnes,
Knut Waterloo,
Silje Bøen Torsetnes,
Berglind Gisladottir
et al.:
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
Alzheimer's and Dementia: Translational Research and Clinical Interventions 10. Nov 2018
ARKIV /
DOI
Tormod Fladby,
Lene Pålhaugen,
Per Selnes,
Knut Waterloo,
Geir Bråthen,
Erik Hessen
et al.:
Detecting at-risk Alzheimer's disease cases
Journal of Alzheimer's Disease 29. Aug 2017
DOI
Bjørn-Eivind Seljelid Bordewic Kirsebom,
Ragna Espenes,
Knut Waterloo,
Erik Hessen,
Stein Harald Johnsen,
Geir Bråthen
et al.:
Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
Journal of Alzheimer's Disease 2017
ARKIV /
DOI
Luiza Chwiszczuk,
Monica Haraldseid Breitve,
Bjørn-Eivind Kirsebom,
Per Selnes,
John Christian Jøraholmen Fløvig,
Anne Brita Knapskog
et al.:
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
Frontiers in Aging Neuroscience 2023
ARKIV /
DOI
Mathilde Suhr Hemminghyth,
Monica Haraldseid Breitve,
Berglind Gisladottir,
Gøril Rolfseng Grøntvedt,
Arne Exner Nakling,
Tormod Fladby
et al.:
Cerebrospinal fluid neurofilament light chain mediates age-related decline in learning and memory in healthy adults
2023
Nikias Ioannis Siafarikas,
Bjørn-Eivind Kirsebom,
Deepak P. Srivastava,
Cecilia Magdalena Eriksson,
Eirik Auning,
Erik Hessen
et al.:
Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression (Scientific Reports, (2021), 11, 1, (20375), 10.1038/s41598-021-99794-9)
Scientific Reports 2022
DOI
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Tormod Fladby,
Marie Eckerström,
Wallin Anders,
Knut Waterloo
et al.:
Demographically adjusted test norms for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults
from 41 to 79 years
2020
Bjørn-Eivind Kirsebom
:
Hva vet vi om Alzheimers sykdom i dag, og finnes det en kur?
Nordlys 21. Sep 2020
DATA
Grit Richter,
Bjørn-Eivind Kirsebom,
Per Selnes,
Kaja Nordengen,
Knut Waterloo,
Berglind Gisladottir
et al.:
Early increase in CSF neurogranin/BACE1 ratio in predementia APOE-ɛ4 homozygote cases with amyloid pathology
2019
Ingvild Vøllo Eliassen,
Bjørn-Eivind Kirsebom,
Erik Hessen,
Per Selnes,
Knut Waterloo,
Tormod Fladby
:
Distractor List Errors from Verbal Learning Test May Reveal Deficient Temporal Memory Encoding in Predementia Alzheimer’s Disease
2019
Johan Jacob Espenes,
Bjørn-Eivind Kirsebom,
Ingvild Eliassen Vøllo,
Ragna Espenes,
Knut Waterloo,
Erik Hessen
et al.:
Demographically adjusted norms for basic and derived measures on the Trail Making Test A & B based on a Norwegian sample age 40 – 84 years.
2019
Bjørn-Eivind Kirsebom
:
Frykter fordobling av demenstilfeller innen 2050: Tromsø-forskere undersøker om blåbær kan være kuren
Bjørn-Eivind Kirsebom,
Tine Viktoria Buberg
:
Forsker på demens: – Antioksidanter fra blåbær kan bidra til å bremse demens
07. Aug 2019
Ragna Espenes,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Knut Waterloo,
Stein Harald Johnsen,
Erik Hessen
et al.:
Medical help-seeking in Subjective Cognitive Decline associated with lower CSF Aβ1-42 and reduced memory performance
2019
Bjørn-Eivind Kirsebom
:
Vil avdekke Alzheimers sykdom så tidlig som mulig
05. Jun 2019
Grit Richter,
Bjørn-Eivind Kirsebom,
Per Selnes,
Kaja Nordengen,
Knut Waterloo,
Berglind Gisladottir
et al.:
An amyloid-coupled pre-dementia increased CSF neurogranin/BACE1 ratio may reflect early synapse affection in APOE-ɛ4 homozygotes
2019
Bjørn-Eivind Kirsebom,
Per Selnes,
Grit Richter,
Berglind Gisladottir,
Marianne Wettergreen,
Silje Bøen Torsetnes
et al.:
Cerebrospinal fluid Neurogranin/BACE1 ratio differentiate normal controls, pre-dementia Alzheimer’s and Parkinson’s disease cases.
2019
Bjørn-Eivind Kirsebom
:
Tromsø-forskere jobber intenst med å løse alzheimer-gåten
28. Dec 2019
Bjørn-Eivind Kirsebom,
Kaja Nordengen,
Per Selnes,
Knut Waterloo,
Britta Brix,
Eugeen Vanmechelen
et al.:
INCREASED CSF NEUROGRANIN/BACE1 RATIO IN AMYLOID POSITIVE SUBJECTS WITH SUBJECTIVE COGNITIVE DECLINE
2018
Bjørn-Eivind Kirsebom,
Ragna Espenes,
Knut Waterloo,
Stein Harald Johnsen,
Tormod Fladby
:
Screening for Alzheimer's Disease: Cognitive Impairent in Self-Referred and Memory Clinic-Referred Patients
2017